Announcements Trials
Browse Landscape

Status

Completed 5

Sponsor Class

INDUSTRY 5

Study Type

Interventional 44Observational 5

Sponsor

Cancer Type

Dermatologic 5

Conditions

Keratosis, Actinic 5

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × 3-ingenyl angelate × Clear all
NCT04202445 2023-06-09

MIKADO

LEO Pharma

Completed
1,218 enrolled
Dermatologic

Keratosis, Actinic

NCT02090465 2019-12-17

Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks

LEO Pharma

Completed
840 enrolled
Dermatologic

Keratosis, Actinic

NCT02362152 2019-12-13

RAPID-ACT

LEO Pharma

Completed
1,168 enrolled
Dermatologic

Keratosis, Actinic

NCT02421471 2019-12-13

PMS to Evaluate the Safety and Efficacy of Picato® Gel

LEO Pharma

Completed
1,324 enrolled
Dermatologic

Keratosis, Actinic

NCT02594436 2019-01-22

PrAKtice

LEO Pharma

Completed
440 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡